Sequenta
Latest round
- Series C
Last raised
- Jul 2013
Total raised
- $33M
Investors
- 3
About Sequenta
Sequenta, Inc.Sequenta, Inc. provides advanced immune-based solutions for cancer diagnostics. Founded in 2008, the company is headquartered in South San Francisco, US. In January 2015, Adaptive Biotechnologies acquired Sequenta for an undisclosed amount.Sequenta, Inc. specializes in Immune Medicine, leveraging the adaptive immune system to develop innovative diagnostic and therapeutic solutions. Their flagship product, clonoSEQ®, provides a highly sensitive next-generation sequencing (NGS)-based assessment of minimal residual disease (MRD) for clinical practice and drug trials, facilitating the detection and quantification of MRD in hematological malignancies.Sequenta, Inc. generates revenue through direct sales and partnerships with healthcare institutions and pharmaceutical companies. The primary revenue streams come from the commercialization of the clonoSEQ® platform for MRD testing, structured around diagnostic services and products.Sequenta, Inc. is focused on developing new products aimed at enhancing immune-based diagnostics and therapeutics. The company aims to expand into new markets across North America and Europe, enhancing their clinical offerings by leveraging their advanced technology. The acquisition by Adaptive Biotechnologies in January 2015 positions Sequenta for strategic growth in the biotech landscape.
Who invested in Sequenta
3 investors across 2 rounds
See all investors in Sequenta
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sequenta
Who invested in Sequenta?
Sequenta has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sequenta raised?
Sequenta has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sequenta last raise money?
Sequenta's most recent round on record is a Series C, in Jul 2013.
What does Sequenta do?
Sequenta is a biotechnology company.
Where is Sequenta headquartered?
Sequenta is headquartered in South San Francisco, US.
Which VCs invest in companies like Sequenta?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sequenta's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Sequenta? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.